SEC Filings

Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

This part of our website contains archival information which will not be considered current and may no longer be accurate.

Filing date	Form	Description	Filing Group	Downloads
10/11/05	AW	Withdrawal of amendment to registration statement filed under the Securities Act	Other	0000950103-05-002156.rtf 0000950103-05-002156.xls 0000950103-05-002156.pdf
12/31/20	UPLOAD	UPLOAD	Other	0000000000-20-012610.rtf 0000000000-20-012610.pdf
12/07/20	UPLOAD	UPLOAD	Other	0000000000-20-011714.rtf 0000000000-20-011714.pdf
08/02/07	UPLOAD	UPLOAD	Other	0000000000-07-037741.pdf
01/05/11	UPLOAD	UPLOAD	Other	0000000000-11-000820.pdf
06/20/07	UPLOAD	UPLOAD	Other	0000000000-07-030258.pdf
12/15/15	UPLOAD	UPLOAD	Other	0000000000-15-057944.pdf
09/20/06	UPLOAD	UPLOAD	Other	0000000000-06-045569.pdf
10/01/10	UPLOAD	UPLOAD	Other	0000000000-10-058207.pdf
01/19/12	UPLOAD	UPLOAD	Other	0000000000-12-003047.pdf

Data provided by Kaleidoscope.

Investor Relations

Stock Quote

Featured Report

Investor Relations

SEC Filings

SEC Filing Keyword Search

Stock Quote

Featured Report